Vaccine alliance Gavi sees $600 million in funding restored

Published Updated



The Trump administration has restored $600 million in funding for Gavi, the Vaccine Alliance, after the organization agreed to accelerate its transition away from vaccines containing the mercury-based preservative thimerosal.

The funding, which Congress had already appropriated and was set to expire Sept. 30, will support childhood vaccination programs in low-income countries.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.